Solex 100mg 30 tablets — Made in Switzerland — Free Delivery

The efficacy and safety of amisulpride when used from puberty to 18 years of age have not been established; data on the use of amisulpride in children with schizophrenia are limited. For this reason, the use of amisulpride between puberty and 18 years of age is not recommended. Amisulpride is contraindicated in children under 15 years of age due to lack of clinical data.

Patients, especially those who drive a car and work with other mechanisms, should be warned about the risk of developing drowsiness, dizziness in connection with the use of this preparation.

To date, there are few data regarding acute overdose of amisulpride. The reported symptoms are mainly the result of an increase in pharmacological activity, which is clinically manifested in dizziness, sedation, coma, arterial hypotension and extrapyramidal symptoms.

There have been reports of fatal cases when used simultaneously with other psychotropic preparations.

The specific antidote for amisulpride is unknown. In the event of an acute overdose, it should be determined whether another preparation was used at the same time and appropriate measures should be taken:

From the side of the nervous system. Very often: possible extrapyramidal symptoms (tremor, rigidity, hypertension, increased salivation, akathisia, hypokinesia, dyskinesia). In most cases, they are moderately pronounced at maintenance doses and partially reversible without discontinuation of amisulpride when prescribing anticholinergic antiparkinsonian preparations. The frequency of extrapyramidal symptoms, which depends on the dose, is very low in patients who are treated for predominantly negative symptoms with doses of 50-300 mg / day. Often: acute dystonia is possible (spasmodic torticollis, oculogyric crises, trismus, and so on). It is reversible without discontinuation of amisulpride when an anticholinergic antiparkinsonian is prescribed. Drowsiness. Infrequently, tardive dyskinesia, characterized by involuntary movements of the tongue and/or facial muscles, has been reported, usually after prolonged use of the preparation. Anticholinergic antiparkinsonian preparations are ineffective or may cause an increase in symptoms. Seizures.

From the nervous system: insomnia, anxiety, agitation, frigidity.

From the digestive system: constipation, nausea, vomiting, dry mouth.

From the endocrine system. An increase in the level of prolactin in the blood plasma, which is reversible after discontinuation of the preparation. This can cause such clinical symptoms: galactorrhea, amenorrhea, gynecomastia, chest pain, erectile dysfunction.

From the side of metabolism and nutrition: weight gain, hyperglycemia.

From the side of the cardiovascular system: arterial hypotension, bradycardia.

From the immune system: allergic reactions.

Store in the original packaging at a temperature of 15-25°C, in a dry, dark place and out of the reach of children.

Expiration date - 36 months.